Gainers
Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.
Grab Hldgs's (NASDAQ:GRAB) short percent of float has risen 17.82% since its last report. The company recently reported that it has 109.98 million shares sold short, which is 4.43% of all regular shares that are available for trading.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.